Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Delivery
Separate intravenous access recommended for fat emulsion infusion in neonates
December 29th, 2005
Fat emulsion delivery through separate intravenous access produces optimal results in neonates undergoing extracorporeal membrane oxygenation (ECMO). In a "prospective, randomized, open-label trial," pharmacologists in the United States sought to "characterize the effects of infusing fat emulsion" during neonatal ECMO "by comparing results from patients receiving fat emulsion through the ECMO circuit with those receiving fat emulsion through separate intravenous access." "A second goal was to identify the optimal route for administration," noted M.L. Buck and coauthors at the University of Virginia. "Nine neonates receiving ECMO who required...
Source: Blood Weekly (2005-12-29)
|
